Delivery Order SPE2DR25D1104-SPE2DR26FK683
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,906.36 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ml) on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's existing federal contract...
- The Defense Logistics Agency awarded a $3,836.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Vaxelis vaccine syringes in 0.5ML quantities. The order, which is non-set-aside and competitively awarded, has an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $8,057.75 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) with a firm fixed price and an ultimate completion date of December 3, 2025. The contract, which carries no set-aside designation, was competitively awarded and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.74 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ML) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award for medical supply procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,278.96 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ml) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under the company's existing contract vehicle...
- The Defense Logistics Agency (DLA) awarded a $9,307.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,557.92 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Vaxelis vaccine syringes (0.5mL) with a completion date of June 6, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) under a firm fixed-price contract valued at $1,947.21, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency has awarded a $7,061.01 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL). This competitively awarded, firm fixed-price contract with an ultimate completion date of October 30, 2025, represents a single delivery order fulfillment under AmerisourceBergen's larger federal contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK683Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,151.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on December 16, 2025, with an ultimate completion date of December 17, 2025. The non-competitive award was placed to the vendor's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, with particular focus on military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The SPE2DX prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning subsequent Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, underscoring the agency's strategic approach to sustaining critical medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/15/25 |